PTC Therapeutics to Participate at Upcoming Investor Conferences

Rhea-AI Summary

PTC Therapeutics (NASDAQ: PTCT) has announced its participation in three major healthcare investor conferences in November and December 2024. The company will present overviews at the UBS Global Healthcare Conference on November 13, the Jefferies London Healthcare Conference on November 19, and Citi's 2024 Global Healthcare Conference on December 3.

All presentations will be available via webcast on PTC's investor relations website and will remain accessible for 30 days after each event. Viewers are advised to connect several minutes before the scheduled start times to ensure proper connection.

News Market Reaction

+1.19%

1 alert

+1.19% News Effect

On the day this news was published, PTCT gained 1.19%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

WARREN, N.J., Nov. 4, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will present a company overview at the following conferences:

UBS Global Healthcare Conference
Wednesday, Nov. 13 at 2:45 p.m. PST / 5:45 p.m. EST

Jefferies London Healthcare Conference
Tuesday, Nov. 19 at 11:30 a.m. GMT / 6:30 a.m. EST

Citi's 2024 Global Healthcare Conference
Tuesday, Dec. 3 at 2:30 p.m. EST

The presentations will be webcast live on the Events and Presentations page under the Investor section of PTC Therapeutics' website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection.

About PTC Therapeutics, Inc.
PTC is a global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to children and adults living with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need. The company's strategy is to leverage its strong scientific expertise and global commercial infrastructure to maximize value for its patients and other stakeholders. To learn more about PTC, please visit us at www.ptcbio.com and follow us on Facebook, on X (formerly Twitter), and on LinkedIn.

For More Information:

Investors:
Investor Relations
+1 (908) 912-9848
ir@ptcbio.com

Media:
Jeanine Clemente
+1 (908) 912-9406
jclemente@ptcbio.com

View original content:https://www.prnewswire.com/news-releases/ptc-therapeutics-to-participate-at-upcoming-investor-conferences-302295727.html

SOURCE PTC Therapeutics, Inc.

FAQ

What investor conferences will PTC Therapeutics (PTCT) attend in November-December 2024?

PTC Therapeutics will attend three conferences: UBS Global Healthcare Conference on November 13, Jefferies London Healthcare Conference on November 19, and Citi's 2024 Global Healthcare Conference on December 3.

How long will PTC Therapeutics (PTCT) conference webcasts be available for viewing?

The conference webcasts will be archived and available for viewing for 30 days following each presentation on PTC's investor relations website.

Where can investors watch PTC Therapeutics (PTCT) conference presentations?

Investors can watch the presentations live on PTC Therapeutics' website at https://ir.ptcbio.com/events-presentations under the Events and Presentations page in the Investor section.

What time is PTC Therapeutics' (PTCT) presentation at the UBS Global Healthcare Conference?

PTC Therapeutics will present at the UBS Global Healthcare Conference on Wednesday, November 13 at 2:45 p.m. PST / 5:45 p.m. EST.